- EUR/USD has fallen from the highs amid renewed dollar strength.
- Falling US yields, Europe's vaccine boost and ECB expectations may push the pair back up.
- Wednesday's four-hour chart is painting a bullish picture.
Two steps up, one step down, and now a fresh rise? That is the impression from looking at the EUR/USD chart – and there are good reasons for seeing the rally resuming after the recent fall.
The greenback has been gaining ground in a risk-off mood – investors have flocked to the safe-haven dollar while stocks declined. This may change soon.
Here are three reasons why the euro may move higher:
1) Change in mood
The much-needed downside equity correction may now make way for a fresh increase, as seen in S&P 500 futures. The Western world is emerging from the virus, as seen in America's decline in COVID-19 cases. A gentle increase in shares may weigh on the dollar.
More importantly, US ten-year yields back below 1.60%, and that could also send the greenback lower, despite a looser correlation between the currency and returns on US debt.
2) Shots in the arm
The European Medicines Agency announced that Johnson & Johnson's single-shot covid vaccines are linked to blood clots – but that these are extremely rare and do not warrant abandoning their usage. Several European countries have accepted that the benefits far outweigh the risks and are set to begin using these jabs as early as Wednesday.
Roughly 20% of Europeans have received one shot, half the rate seen in the US. J&J's is set to send a total of 55 million shots to the EU in the second quarter, covering around 11% of the population – in addition to all the other vaccines. That implies a quicker exit from the crisis.
3) Cavalry is coming
The mix of a quicker immunization effort, US demand, and other factors may lead the European Central Bank to upgrade its language and perhaps signal less support is needed. Investors may better position themselves ahead of Thursday's event.
Another boost comes from Germany, where the Constitutional Court gave the green light to deploy massive fiscal support approved last year. While there were few doubts about the decision from Karlsruhe, it provides another sigh of relief.
All in all, there is room for EUR/USD to resume its gains.
EUR/USD Technical Analysis
The four-hour chart is showing a clear uptrend so far during April. The recent descend from the highs still leaves momentum pointing to the upside and the currency pair above the 50, 100, and 200 Simple Moving Averages (SMAs). Moreover, the Relative Strength Index (RSI) is below 70, outside overbought conditions.
Some resistance awaits at 1.2045, which was an initial high point early in the week, followed by 1.2080, April's high. It is followed by 1.2130 and 1.22.
Critical support is at the round 1.20 level, followed by 1.1940 and 1.1925. Further down,m 1.1860 is a significant cushion.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.